nicotine
…ally, as demonstrated by several ENDS marketed today. Combining nicotine flux and puff duration regulation is feasible today and provide…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 2,221–2,280 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
betablockers2biologic disease-modifying antirheumatic drugs2botensilimab2brivaracetam2calcium channel blocker2capsule sponge2carbon tetrachloride2ceftazidime-avibactam2cephalexin2chemo-IO2chlorpromazine2chondroitin sulfate2ciclesonide2ciltacabtagene autoleucel2cinacalcet2clodronate liposomes2clomipramine2colchicine-resistant2coumadin2covid vaccines2cross sex hormones2cyclosporine A2darunavir2deferasirox2deferoxamine2desvenlafaxine2dimercaprol2direct oral anticoagulant2docosahexaenoic acid2dolutegravir-based2drug-eluting stents2emergency medications2endothelin-receptor antagonists2eribulin2essential antibiotics2ferric derisomaltose2fibrates2fluoride2fluticasone furoate2fluticasone propionate2fomepizole2fonofos2fostamatinib2furazolidone2galantamine2garlic2glucagon-like peptide-1 (GLP-1) agonists2glucocorticoid-related2glycopeptides2glycoprotein IIb/IIIa2glycopyrronium bromide2hallucinogens2high caffeine2high dose steroids2high-dose statins2high-flow oxygen2hormone blockers2hydrocodone2hydroxyzine2hyoscine butylbromide2
Articles mentioning drugs
10,506 articles · page 476 of 876Turmeric/epigallocatechin-3-gallate (EGCG) emulgelturmeric/EGCG emulgelcutaneous diseasesdermatological diseasesChiang Mai University
…ating skin reactions is crucial in topical product development. Turmeric/epigallocatechin-3-gallate (EGCG) emulgel demonstrates therapeutic potential for cutaneous diseases, warr…
ClobazamLacosamidePerampanelGould Syndromeketogenic diet therapypentobarbital burst suppressionSRSERSE
…olved after 1 week of pentobarbital coma. She was discharged on Clobazam, Perampanel and Lacosamide, with persistent hypotonia and rare …
MMSMicronutrient deficienciesanaemia
…nd household relationships. Women will receive three bottles of MMS (180 tablets each) over 18 months. Quantitative data collection…
semaglutideobesity
…t loss, lifestyle changes and semaglutide treatment. To receive semaglutide treatment, patients were required to participate in GCs focused…
metforminprostate cancer (PC)PC
…nduct safety assessments and (iii) evaluate the efficacy of the metformin and SBRT combination.Methods and analysis We conducted a prospe…
IL-15C7Rsolid tumorshematological malignancies
…term tumor control compared with CAR-NK cells supplemented with IL-15. Similar results were seen using C7R-expressing CD19.CAR-NK cel…
B+tuberculosisTBAF–TBACF
… there was significant geographical variation in yields of both B+ and AF-TB, supporting targeting of interventions in areas of hi…
rocuroniumremifentanilprostatic adenocarcinoma
…se volatile agent with continuous infusions of remifentanil and rocuronium. This approach ensured stable haemodynamics, adequate sedation …
Proton pump inhibitoranticentromeremyositisinterstitial lung diseasesystemic sclerosis (SSc)pulmonary hypertensionUK tertiary referral centreSSc
…The most common symptoms were reflux (32%) and dysphagia (28%). Proton pump inhibitor use was high (81%). Both anticentromere (p=<0.001) and anti-Scl…
0.5% ropivacaineropivacaineNumeric Rating ScalePeripheral nerve blockadeNCT03208478
…her CFNB or CACB. All patients received a 20 mL loading dose of 0.5% ropivacaine and were discharged with a 0.2% ropivacaine infusion (5 mL/hour…
itraconazoleamoxicillinbronchial asthmaantituberculous therapyMycobacterium tuberculosisABPA
…nimal Mycology (ISHAM) guidelines. The patient was treated with itraconazole and a tapering course of oral prednisolone. At the 6-month foll…